Imagion Biosystems
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
385 Bourke St L 11 Ste 2, Melbourne, Vic...Phone Number
+61396927222Website
www.imagionbiosystems.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Imagion Biosystems
Imagion Biosystems is a clinical-stage medical imaging company developing MagSense®, a molecular MRI platform designed to improve cancer detection. By using targeted magnetic nanoparticles, Imagion aims to add molecular specificity to MRI, enabling earlier and more accurate identification of tumors. Its lead focus is HER2-positive breast cancer, with potential applications across multiple cancers.Explore more
Imagion Biosystems Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Imagion Biosystems your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Imagion Biosystems launches new products
Website visits: Recent activity has been detected on your website
Check out if Imagion Biosystems is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Imagion Biosystems has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Imagion Biosystems
Earning: See what the market has to say on Imagion Biosystems recently announced quarterly report
Funding: Get notified immidiatlly once Imagion Biosystems has new funding data
Click to see if Imagion Biosystems had a recent Job posting/layoffs
Imagion Biosystems, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Imagion Biosystems
Compare insights from companies similar to Imagion Biosystems, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Imagion Biosystems financials insights
Gather financial insights about Imagion Biosystems, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$3M
2026
Stock/Share Issuance
$2.6M
Imagion Biosystems Tech Stack
A closer look at the technologies used by Imagion Biosystems
Most Recent Scoops
Funding
Funding
Funding
Funding
Open Position
Imagion Biosystems is currently seeking a Director, Quality Assurance. (San Diego, CA)
Promotion
Promotion
Executive Move
Promotion
Imagion Biosystems News & Media
Imagion Biosystems Full Year 2024 Earnings: AU$0.046 loss per share (vs AU$0.41 loss in FY 2023)
Imagion Biosystems ( ASX:IBX ) Full Year 2024 Results Key Financial Results Revenue: AU$2.67m (down 46% from FY 2023...Imagion Biosystems Boosts Funding and Secures Licensing Deal - TipRanks.com
Imagion Biosystems Ltd. (AU:IBX) has released an update. Imagion Biosystems Ltd. has secured $3 million in new funding through a share placement led by CPS Capital,...Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging Agent
MELBOURNE, Australia and SAN DIEGO, Dec. 13, 2023 /PRNewswire/ -- Imagion Biosystems Limited (ASX: IBX) recently announced positive results following completion of the IBI10103 phase I clinical trial evaluating the safety and clinical feasibility of MagSense® HER2 Imaging Agent (MSH2IA)...Imagion Biosystems Secures AU$3.5 Million R&D Tax Rebate for Fiscal Year 2022
-- Imagion Biosystems secured a AU$3.5 million rebate for the fiscal year ended June 30, 2022 from the Australian government’s research and development tax incentive scheme. The refund is higher...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Imagion Biosystems
Sign Up For FreeTo access detailed company insights
Imagion Biosystems is a clinical-stage medical imaging company developing MagSense®, a molecular MRI platform designed to improve cancer detection. By using targeted magnetic nanoparticles, Imagion aims to add molecular specificity to MRI, enabling earlier and more accurate identification of tumors. Its lead focus is HER2-positive breast cancer, wi... Read More
